467 results on '"Jäck, Hans-Martin"'
Search Results
2. Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
3. Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5
4. IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity
5. Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage
6. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
7. Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
8. Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses
9. No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
10. GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunity
11. The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
12. Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance
13. Identification of TFG- and Autophagy-Regulated Proteins and Glycerophospholipids in B Cells.
14. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
15. Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
16. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
17. APOBEC3 enzymes restrict marginal zone B cells
18. Identification of miR-128 Target mRNAs That Are Expressed in B Cells Using a Modified Dual Luciferase Vector
19. Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3
20. Unraveling the mysteries of plasma cells
21. BCL6 is critical for the development of a diverse primary B cell repertoire
22. The intestine: A highly dynamic microenvironment for IgA plasma cells
23. Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage
24. Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
25. The microRNA processing subunit DGCR8 is required for a T cell-dependent germinal center response
26. The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
27. Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
28. Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75
29. Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
30. SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
31. Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
32. Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy
33. BAFFR activates PI3K/AKT signaling in human naive but not in switched memory B cells through direct interactions with B cell antigen receptors
34. Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
35. Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
36. SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
37. Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
38. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
39. Single‐cell resolution of plasma cell fate programming in health and disease
40. The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic
41. Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
42. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
43. Metabolic profiling of single cells by exploiting NADH and FAD fluorescence via flow cytometry.
44. B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
45. A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants
46. A surrogate cell‐based SARS‐CoV‐2 spike blocking assay (SUBA)
47. A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model
48. DGCR8 deficiency impairs macrophage growth and unleashes the interferon response to mycobacteria
49. Roles of Heavy and Light Chains in IgM Polymerization
50. Bispecific Antibodies that Mediate Killing of Cells Infected with Human Immunodeficiency Virus of Any Strain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.